Db. Roth et Hw. Flynn, ANTIBIOTIC SELECTION IN THE TREATMENT OF ENDOPHTHALMITIS - THE SIGNIFICANCE OF DRUG-COMBINATIONS AND SYNERGY, Survey of ophthalmology, 41(5), 1997, pp. 395-401
Emerging resistance of organisms to standard antibiotic therapy has fo
rced clinicians to continually evaluate the best intraocular antibioti
cs for the treatment of endophthalmitis. Early diagnosis and appropria
te treatment with intraocular antibiotics are important factors in the
successful management of endophthalmitis. Although drug combinations
are necessary to cover the full range of bacteria causing endophthalmi
tis, antimicrobial synergy is probably less important in endophthalmit
is treatment because of the high intravitreal concentration of individ
ual antibiotics achieved by intravitreal injection. In the treatment o
f bacterial endophthalmitis, the combination of intravitreal vancomyci
n (1 mg/0.1 cc) and ceftazidime (2.25 mg/0.1 cc) is a reasonable alter
native to the combination vancomycin and amikacin (0.4 mg/0.1 cc). (C)
1997 by Elsevier Science Inc.